Dr. Tae Han Kim is the founding CEO of Samsung Biologics, a contract development and manufacturing organization (CDMO) that helps its clients develop and manufacture complex bio-medicines for patients who suffer from a wide range of diseases. Dr. Kim has a chemical engineering doctoral degree from the University of Texas at Austin.
Before getting started with Samsung Biologics, he worked in a number of Samsung divisions beginning in 1979.
After serving in Samsung Group's Strategic Planning Office and holding a senior leadership position at Samsung Total Petrochemicals, he restructured the financial models of Samsung General Chemicals. He also developed an aromatics plant, naphtha cracking center, and polypropylene and styrene monomer production plants.
